秒速时时彩

Public announcement of the environmental protection acceptance monitoring and acceptance report on the phased completion of the FDA production center project of the new drug preparation supporting raw materials of CSPC (and the second phase of Sino-Nano Relocation and Upgrade Project)

Posted: December 02, 2019 Posted by: CSPC


According to the "Decision of the State Council on Amending the" Regulations on the Environmental Protection Management of the Completion of Construction Projects "" (Decree No. 682 of the State Council), the "Announcement on Promulgation" by the Ministry of Environmental Protection (Guo Huan Jian EIA [2017] No. 4), and the "Environment of Construction Projects" The requirements for the approval of impact assessment documents and the construction unit ’s independent implementation of environmental protection facility inspection and acceptance guidelines (for trial implementation) (Jihuanbanzihan [2017] No. 727) requirements, now “Stone Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd.” The “Environmental Protection and Acceptance Monitoring Report Form for Completion of the Industrialization of Pharmaceutical Preparations Project” is published as follows:

Project Name: FDA Production Center Project of New Pharmaceutical Preparation Supporting Materials of CSPC (and Sino-Nano Relocation and Upgrade Project Phase II) Phase Project

Construction unit: CSPC Ouyi Pharmaceutical Co., Ltd.

Public content: Acceptance report, acceptance opinions, and list of acceptance groups, see the attachment for details: http://pan.baidu.com/s/1vCsweroqM1dwQS4uYcRoBQ Extraction code: pT4Z

Publicity time: 2019.12.2- 2019.12.31

During the publicity period, if you have any objections to the above publicity content, please write back to CSPC Ouyi Pharmaceutical Co., Ltd.

Li Yang, feedback telephone: 0311-87171523

CSPC Ouyi Pharmaceutical Co., Ltd.

December 2, 2019